Emerging Strategies in Tuberculosis Treatment: Q203 and PBTZ169 Synergy in Focus

EasyChair Preprint no. 11872

Abstract

This study investigates the burgeoning approach of synergistic drug combinations in tuberculosis treatment, focusing on the tandem use of Q203 and PBTZ169. The study marks a pivotal contribution to the evolving landscape of tuberculosis therapy. The identified synergy between Q203 and PBTZ169 opens avenues for innovative treatment strategies against Mycobacterium tuberculosis. The research underscores the importance of investigating synergistic drug interactions, offering a potential paradigm shift in the battle against tuberculosis. The outcomes provide valuable insights for future developments in tuberculosis treatment, emphasizing the significance of exploring emerging strategies to enhance therapeutic efficacy.

Keyphrases: PBTZ169, Q203, Tuberculosis

@Booklet{EasyChair:11872,
  author = {Kurez Oroy and Danny Jhonson},
  title = {Emerging Strategies in Tuberculosis Treatment: Q203 and PBTZ169 Synergy in Focus},
  howpublished = {EasyChair Preprint no. 11872},

  year = {EasyChair, 2024}}